1. Home
  2. GTN vs TBPH Comparison

GTN vs TBPH Comparison

Compare GTN & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gray Television Inc.

GTN

Gray Television Inc.

HOLD

Current Price

$5.31

Market Cap

468.6M

Sector

Industrials

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.12

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTN
TBPH
Founded
1897
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
468.6M
993.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTN
TBPH
Price
$5.31
$18.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$7.60
$27.80
AVG Volume (30 Days)
1.1M
516.8K
Earning Date
11-07-2025
11-10-2025
Dividend Yield
6.02%
N/A
EPS Growth
N/A
N/A
EPS
0.43
0.58
Revenue
$3,348,000,000.00
$80,327,000.00
Revenue This Year
N/A
$70.78
Revenue Next Year
$13.42
N/A
P/E Ratio
$12.36
$31.31
Revenue Growth
N/A
27.12
52 Week Low
$2.91
$7.90
52 Week High
$6.31
$20.33

Technical Indicators

Market Signals
Indicator
GTN
TBPH
Relative Strength Index (RSI) 59.88 54.58
Support Level $4.57 $17.25
Resistance Level $4.87 $20.32
Average True Range (ATR) 0.22 0.73
MACD 0.08 -0.28
Stochastic Oscillator 77.92 30.62

Price Performance

Historical Comparison
GTN
TBPH

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: